vs
Metropolitan Bank Holding Corp.（MCB）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Metropolitan Bank Holding Corp.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.2倍（$88.5M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 25.4%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 14.3%）
该企业是一家银行控股公司，总部位于马里兰州奥尔尼，业务覆盖华盛顿大都会区。除核心银行业务外，公司还提供商保个人险、保证担保、工伤保险、职业责任险等多种保险产品，同时为高净值个人、企业及机构提供理财规划、财富管理与资产管理服务，2025年4月该公司被收购。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
MCB vs PBYI — 直观对比
营收规模更大
MCB
是对方的1.2倍
$75.5M
营收增速更快
PBYI
高出2.4%
25.4%
两年增速更快
PBYI
近两年复合增速
14.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $88.5M | $75.5M |
| 净利润 | $31.4M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 35.5% | — |
| 营收同比 | 25.4% | 27.7% |
| 净利润同比 | 92.2% | — |
| 每股收益（稀释后） | $2.92 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MCBPBYI
| Q1 26 | $88.5M | — | ||
| Q4 25 | $88.4M | $75.5M | ||
| Q3 25 | $79.8M | $54.5M | ||
| Q2 25 | $76.3M | $52.4M | ||
| Q1 25 | $70.6M | $46.0M | ||
| Q4 24 | $71.0M | $59.1M | ||
| Q3 24 | $71.5M | $80.5M | ||
| Q2 24 | $67.7M | $47.1M |
净利润MCBPBYI
| Q1 26 | $31.4M | — | ||
| Q4 25 | $28.9M | — | ||
| Q3 25 | $7.1M | $8.8M | ||
| Q2 25 | $18.8M | $5.9M | ||
| Q1 25 | $16.4M | $3.0M | ||
| Q4 24 | $21.4M | — | ||
| Q3 24 | $12.3M | $20.3M | ||
| Q2 24 | $16.8M | $-4.5M |
毛利率MCBPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率MCBPBYI
| Q1 26 | — | — | ||
| Q4 25 | 46.6% | 22.7% | ||
| Q3 25 | 12.8% | 17.6% | ||
| Q2 25 | 35.1% | 12.7% | ||
| Q1 25 | 33.1% | 8.7% | ||
| Q4 24 | 44.1% | 22.6% | ||
| Q3 24 | 24.6% | 27.4% | ||
| Q2 24 | 35.3% | -4.6% |
净利率MCBPBYI
| Q1 26 | 35.5% | — | ||
| Q4 25 | 32.6% | — | ||
| Q3 25 | 8.9% | 16.2% | ||
| Q2 25 | 24.6% | 11.2% | ||
| Q1 25 | 23.2% | 6.5% | ||
| Q4 24 | 30.2% | — | ||
| Q3 24 | 17.2% | 25.2% | ||
| Q2 24 | 24.8% | -9.6% |
每股收益（稀释后）MCBPBYI
| Q1 26 | $2.92 | — | ||
| Q4 25 | $2.74 | $0.26 | ||
| Q3 25 | $0.67 | $0.17 | ||
| Q2 25 | $1.76 | $0.12 | ||
| Q1 25 | $1.45 | $0.06 | ||
| Q4 24 | $1.89 | $0.40 | ||
| Q3 24 | $1.08 | $0.41 | ||
| Q2 24 | $1.50 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $948.3M | $130.3M |
| 总资产 | $8.8B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资MCBPBYI
| Q1 26 | — | — | ||
| Q4 25 | $393.6M | $97.5M | ||
| Q3 25 | $385.9M | $94.4M | ||
| Q2 25 | $152.5M | $96.0M | ||
| Q1 25 | $196.5M | $93.2M | ||
| Q4 24 | $200.3M | $101.0M | ||
| Q3 24 | $318.5M | $96.7M | ||
| Q2 24 | $244.7M | $96.8M |
总债务MCBPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益MCBPBYI
| Q1 26 | $948.3M | — | ||
| Q4 25 | $743.1M | $130.3M | ||
| Q3 25 | $732.0M | $115.3M | ||
| Q2 25 | $723.0M | $104.7M | ||
| Q1 25 | $737.8M | $97.1M | ||
| Q4 24 | $729.8M | $92.1M | ||
| Q3 24 | $715.2M | $71.1M | ||
| Q2 24 | $692.4M | $48.5M |
总资产MCBPBYI
| Q1 26 | $8.8B | — | ||
| Q4 25 | $8.3B | $216.3M | ||
| Q3 25 | $8.2B | $202.9M | ||
| Q2 25 | $7.9B | $194.9M | ||
| Q1 25 | $7.6B | $196.2M | ||
| Q4 24 | $7.3B | $213.3M | ||
| Q3 24 | $7.4B | $220.7M | ||
| Q2 24 | $7.3B | $205.0M |
负债/权益比MCBPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流MCBPBYI
| Q1 26 | — | — | ||
| Q4 25 | $88.7M | $14.4M | ||
| Q3 25 | $31.8M | $9.7M | ||
| Q2 25 | $18.4M | $14.1M | ||
| Q1 25 | $7.8M | $3.6M | ||
| Q4 24 | $148.5M | $15.6M | ||
| Q3 24 | $4.8M | $11.0M | ||
| Q2 24 | $35.3M | $1.0M |
自由现金流MCBPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M |
自由现金流率MCBPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% |
资本支出强度MCBPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% |
现金转化率MCBPBYI
| Q1 26 | — | — | ||
| Q4 25 | 3.07× | — | ||
| Q3 25 | 4.47× | 1.10× | ||
| Q2 25 | 0.98× | 2.41× | ||
| Q1 25 | 0.47× | 1.21× | ||
| Q4 24 | 6.93× | — | ||
| Q3 24 | 0.39× | 0.54× | ||
| Q2 24 | 2.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
